LN-668934
Pyridine, 3-(3-ethoxyandrosta-5,16-dien-17-yl)- , 0.95 , 2484719-14-2
Update time: 2023-04-23
PRODUCT Properties
| Boiling point: | 493.9±45.0 °C(Predicted) |
| Density | 1.09±0.1 g/cm3(Predicted) |
| storage temp. | 2-8°C |
| solubility | Chloroform (Slightly), DMSO (Slightly), Ethyl Acetate (Slightly) |
| pka | 5.31±0.12(Predicted) |
| form | Solid |
| color | White to Off-White |
| Major Application | pharmaceutical small molecule |
Description and Uses
Abiraterone Ethyl Ether is an impurity of Abiraterone (A108490), a steroidal cytochrome P 450 17a-hydroxylase-17,20-lyase inhibitor (CYP17), is currently undergoing phase II clinical trials as a potential drug for the treatment of androgen-dependent prostate cancer.
Safety
| Symbol(GHS) |   GHS08,GHS09 |
| Signal word | Danger |
| Hazard statements | H360F-H373-H410 |
| Precautionary statements | P202-P260-P273-P280-P308+P313-P391 |
| target organs | Endocrine system |
| WGK Germany | WGK 3 |
| Storage Class | 6.1C - Combustible acute toxic Cat.3 toxic compounds or compounds which causing chronic effects |
| Hazard Classifications | Aquatic Chronic 1 Repr. 1B STOT RE 2 |